Yangzijiang Pharmaceutical Group's sales in 2018 increased by 14.95% year-on-year


China Economic Net, Beijing, January 1st Yesterday, Yangtze River Pharmaceutical Group held a 2018 year-end work conference to seriously summarize the production and operation work of the year, grandly commend advanced collectives and advanced workers, and carefully deploy the development plan for 2019. Xu Jingren, secretary of the party committee and chairman of the group, made a work report to the conference. Taizhou Municipal Party Committee Secretary Han Liming attended the meeting and delivered a speech.

In the past 2018, facing the complicated domestic and international economic situation, Yangzijiang Pharmaceutical Group firmly took the road of high-quality development, comprehensively and in-depth reform and innovation, promoted the supply-side structural reform, seized the strategic opportunity of great health, and achieved cumulative output value and sales , Profits and taxes increased by 14.69%, 14.95% and 17.66% respectively year-on-year. The performance exceeded expectations and outperformed the industry average growth rate. Successively won the first place in the 2017 China Top 100 Pharmaceutical Industry Enterprises List, the first place in the Chemical Pharmaceutical Industry Top 100 Comprehensive Strength List, the first place in the China Quality Award Nomination Award, and the first place in the brand strength of China's brand value evaluation in the medical and health sector. , No. 1 in the total number of first prizes in the QC Achievement Appraisal of the National Pharmaceutical Industry. The company was successfully selected into the National Brand Project of Xinhua News Agency, the National Standards Committee "Chinese Medicine Process Intelligent Manufacturing National High-tech Industry Standardization Pilot", and was also awarded China’s 500 Most Valuable Brands, Jiangsu Enterprise Technology Innovation Award, Taizhou Outstanding Contribution Taxpayer, Reform and Opening-up With the title of Outstanding Enterprise in the Pharmaceutical Industry, Chairman Xu Jingren was elected as "Advanced Individual Who Made Outstanding Contributions to Reform and Opening Up" and "Memorial of Meritors in the Pharmaceutical Industry for 40 Years of Reform and Opening Up" With a record operating performance, the people of Yangtze River have delivered a dazzling report card for 40 years of reform and opening up, which has also added a touch of spring to the pharmaceutical industry in the cold winter.

Counting the achievements of Yangtze River Pharmaceutical in the past year, many are remarkable. The most impressive thing is that it has achieved fruitful results in R&D and innovation. It has obtained 10 production approvals for chemical drugs and traditional Chinese medicines, 2 innovative drugs have entered clinical research, and 5 varieties have passed the quality and efficacy consistency evaluation of generic drugs, achieving import substitution and further development. Enhanced. The most demonstrating corporate heritage is that Yang Zijiang won gold and silver in the domestic and foreign quality evaluations, and won the first prize of the national pharmaceutical industry quality management QC results evaluation for the total number of "14 consecutive championships"; participated in the 43rd International Quality Management Group Conference, and courageously Won 4 QC International Gold Awards. The Group's quality risk management and control model won the "Asian Quality Innovation Award". In the third "China Quality Award" selection, Yang Zijiang won the nomination award again and jumped to the first place in the nomination award.

Standing at a new starting point for development, the people of Yangtze River took the lead, adjusted the standard to the highest level, and pushed the reform forward in depth. Xu Jingren said that to create a new era and new cause for the Yangtze River, we must use greater courage to comprehensively promote self-innovation, greater determination and high-level development of high-quality development, and greater initiative to put people’s health as a development priority strategy. Great wisdom moves toward the center of the world medical stage. In response to changes in the pharmaceutical market, Yangtze River Pharmaceutical Group is promoting management reform in all aspects, decomposing and implementing the goals and tasks for 2019, and the internal competitive atmosphere is becoming increasingly strong. With full confidence, the people of Yangtze River set off again to pursue high-quality development, and strive to present the 70th anniversary of the founding of the People's Republic of China with better performance.

Han Liming, on behalf of the municipal party committee and the municipal government, congratulated Yangtze River Pharmaceutical Group on its extraordinary achievements, and hoped that the company will further establish innovative thinking, highlight quality and efficiency, continue to transform and upgrade, lead and ensure the development of the company with high-quality party building, and strive to seize opportunities. Seek breakthroughs in transformation and development, pursue excellence in casting brand, and continue to rise in economic benefits, strive to develop Yangtze River into a leading domestic and world-renowned enterprise, and make new and greater contributions to building a healthy city and a state of prosperity.

The conference commended the advanced collectives and advanced workers that emerged from the work in the past year. 309 model workers, outstanding management cadres and heads of advanced departments were on the podium. Leaders participating in the meeting presented gold medals and certificates to the winners and took a group photo.